Ferroptosis: A Double-Edged Sword in Cisplatin-Based Cancer Therapy and Acute Kidney Injury
Cancer Management and Research · 2026-03 · Volume 18 · 1-14
DOI: 10.2147/cmar.s589114 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Management and Research, 2026-03. Verfasst von Suansuan Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Unit, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, 130021, People's Republic of China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Intensive Care Unit, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, 130021, People's Republic of China.
- Department of Pulmonology, The Third Affiliated Clinical Hospital to Changchun University of Chinese Medicine, Changchun, 130117, People's Republic of China.
- Department of Emergency, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, 130021, People's Republic of China.
Zitieren
APA
Zhou, S., Xiao, Y., & Fang, L. (2026). Ferroptosis: A Double-Edged Sword in Cisplatin-Based Cancer Therapy and Acute Kidney Injury. Cancer Management and Research, Volume 18, 1-14. https://doi.org/10.2147/cmar.s589114
Vancouver
Zhou S, Xiao Y, Fang L. Ferroptosis: A Double-Edged Sword in Cisplatin-Based Cancer Therapy and Acute Kidney Injury. Cancer Management and Research. 2026;Volume 18:1-14. doi:10.2147/cmar.s589114
BibTeX
@article{Zhou2026,
author = {Zhou, Suansuan and Xiao, Yue and Fang, Li},
title = {Ferroptosis: A Double-Edged Sword in Cisplatin-Based Cancer Therapy and Acute Kidney Injury},
journal = {Cancer Management and Research},
year = {2026},
volume = {Volume 18},
pages = {1--14},
doi = {10.2147/cmar.s589114}
}
EUVIMED